Ionizable Cationic Lipid Structure for Oxidation-Resistant LNP Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing ionizable cationic lipids used in lipid nanoparticles (LNPs) for nucleic acid delivery are susceptible to oxidative degradation during storage, compromising their stability and transfection activity.
Innovation Solution
Designing cationic lipids with at least two carbon-carbon double bonds separated by at least two methylene groups, which enhances resistance to oxidative degradation while maintaining high transfection activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cationic lipids contain double bonds separated by one methylene group (e.g., linoleic acid structure), then desirable biological properties and transfection activity are achieved, but sensitivity to oxidative degradation increases
Solution Approach 1:
The patent changes the structural parameter of the lipid molecule by increasing the number of methylene groups separating double bonds from one to at least two. This parameter modification reduces the electron density and accessibility of the double bonds to oxidizing agents, thereby decreasing oxidative degradation sensitivity while preserving the essential transfection activity through maintained amphipathic properties and membrane interaction capability.
Solution Approach 2:
The patent applies local quality modification by specifically altering the hydrophobic tail region of the cationic lipid while keeping the hydrophilic head group intact. The modified hydrophobic tail with increased methylene spacing provides localized protection against oxidation, while the unchanged head group maintains the necessary biological functionality for nucleic acid delivery and cellular transfection.
2Stability of the object's composition
If cationic lipids are modified to resist oxidation, then storage stability improves, but transfection activity may be compromised
Solution Approach 1:
The patent optimizes the parameter of methylene group spacing to at least two groups, which strikes a balance between oxidation resistance and transfection functionality. This specific parameter change provides sufficient steric protection to double bonds for enhanced storage stability, while maintaining the lipid's ability to form stable nanoparticles and interact with cellular membranes for effective transfection.
Solution Approach 2:
The patent creates a composite lipid structure combining a modified hydrophobic tail with enhanced oxidation resistance and a standard hydrophilic head group with proven transfection capability. This composite approach allows the molecule to exhibit both improved storage stability from the modified tail and maintained transfection activity from the functional head group, resolving the contradiction between stability and efficacy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modified lipids exhibit significantly reduced oxidation byproducts and retain high transfection efficiency, improving the stability and tolerability of nanoparticles in vivo.
Implementation Method 1
Lipid nanoparticles (LNP) are used for the delivery of therapeutic nucleic acids to cells
Implementation Method 2
certain ICL compounds are undesirably sensitive to oxidation during storage
Data Source
AI summary
The present disclosure provides compounds useful as ionizable cationic lipids. The ionizable cationic lipids are useful for preparing lipid nanoparticles for the delivery of therapeutic nucleic acids to cells. Cationic ionizable lipids were engineered with improved stability to oxidative degradation while in storage.